Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Bionik Laboratories Corp

Company price
0.0001 USD 0.00(0%)
Last update at 2026-11-19T21:00:00Z
VOLUME
578
Market Cap
0.00M

Momentum Score

…

Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
0.00
Low
0.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Bionik Laboratories Corp develops and commercializes robotic and assistive technologies for physical rehabilitation and mobility. Long-term growth drivers include aging populations, rising prevalence of neurologic and mobility impairments, and increasing interest in robotic solutions for clinical and home-based therapy, which may benefit demand and support gradual market expansion.

Key risks include limited liquidity and disclosure typical of Pink-sheet listings, execution and commercialization challenges, regulatory and reimbursement uncertainty, and likely need for additional financing that could dilute shareholders.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
1.81M
Revenue Per Share
0.26
Gross Profit TTM
0.99M
Debt / Equity
-1.47
ROE
-768.84%
Net Debt
1.98M
ROCE
-458.24%
Diluted EPS TTM
-0.72

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Income before tax -4.95M -10.41M -13.62M -25.02M -10.56M
Net income -13839.95M -15.61M -13.96M -24.93M -10.56M
Selling general administrative 2.93M 2.81M 4.57M 5.98M 5.24M
Selling and marketing expenses 1.98M 1.92M 1.02M 2.17M 2.34M
Gross profit 0.99M 0.95M 0.92M 1.26M 1.62M
Reconciled depreciation 0.06M 0.10M 0.19M 0.38M 0.35M
Ebit -4.83M -4.77M -6.16M -11.25M -7.29M
Ebitda -4.78M -4.38M -6.03M -10.87M -6.94M
Depreciation and amortization 0.05M 0.39M 0.12M 0.38M 0.35M
Operating income -4.83M -4.77M -6.16M -11.25M -7.29M
Other operating expenses 6.63M 6.05M 7.35M 13.32M 12.73M
Interest expense 0.11M 0.83M 0.41M 0.00M 3.27M
Interest income - - - 0.10M 0.07M
Net interest income -0.11M -0.83M -0.41M 0.00M -3.27M
Income tax expense 13835.00M 5.20M 0.34M -0.08M -0.00M
Total revenue 1.81M 1.27M 1.19M 2.15M 3.25M
Total operating expenses 5.81M 5.73M 7.08M 12.42M 11.10M
Cost of revenue 0.82M 0.32M 0.27M 0.89M 1.63M
Total other income expense net -0.12M -5.64M -7.47M -13.77M -3.27M
Net income from continuing ops -4.95M -10.41M -13.62M -25.02M -10.56M
Net income applicable to common shares -4.95M -10.41M -13.62M -25.02M -10.56M
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Total assets 3.36M 4.68M 8.79M 18.52M 30.68M
Intangible assets 0.03M - 0.98M 1.45M 4.43M
Other current assets 862603.00M 1.13M 1680557.00M 1.59M 1.37M
Total liab 5.00M 1.75M 5.51M 5.20M 3.27M
Total stockholder equity -1.64M 2.93M 3.28M 13.32M 27.41M
Other current liab 1.39M 0.87M 0.76M 1.65M 1.65M
Common stock 0.01M 0.01M 0.01M 0.01M 0.00M
Capital stock 0.01M 0.01M 0.01M 0.01M 0.00M
Retained earnings -100.35M -95.40M -84.99M -71.37M -46.36M
Other liab 0.30M 0.26M 0.30M 0.42M -
Good will 0.10M 0.00M 4.28M 11.09M 22.31M
Other assets 0.01M - - - -
Cash 0.43M 1.99M 0.61M 2.27M 0.45M
Total current liabilities 2.31M 1.49M 4.10M 5.20M 3.27M
Current deferred revenue 0.34M 0.31M 0.27M 0.62M 0.47M
Net debt 1.98M -1.99M 3.11M -0.19M -0.45M
Short term debt 0.02M - 2.61M 2.08M -
Short long term debt - - 2.61M 2.08M -
Short long term debt total 2.41M - 3.72M 2.08M -
Other stockholder equity 98.67M 98.29M 88.23M 84.64M 73.72M
Property plant equipment 0.44M 0.09M 0.09M 0.15M 0.19M
Total current assets 2.78M 4.58M 3.43M 5.83M 3.75M
Net tangible assets -1.77M 2.93M -1.98M 0.78M 0.67M
Net receivables 0.45M 0.27M 2.13M 0.91M 2.90M
Long term debt 2.16M - 1.11M - -
Inventory 1.03M 1.19M 0.69M 1.06M 0.41M
Accounts payable 0.56M 0.31M 0.45M 0.86M 1.15M
Accumulated other comprehensive income 0.03M 0.03M 0.04M 0.04M 0.04M
Common stock total equity - - - 0.01M 0.00M
Non currrent assets other 0.01M - - - 26.93M
Non current assets total 0.58M 0.09M 5.35M 12.69M 26.93M
Capital lease obligations 0.26M - - - -
Breakdown 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Type yearly yearly yearly yearly yearly
Date 2023-03-31 2022-03-31 2021-03-31 2020-03-31 2019-03-31
Investments -0.22M -0.01M - -0.16M -0.10M
Change to liabilities 0.34M -0.15M -0.45M -0.14M 0.77M
Total cashflows from investing activities -0.22M -0.01M -0.01M -0.16M -0.10M
Net borrowings 2.05M 5.55M 2.96M 11.05M 9.27M
Total cash from financing activities 2.05M 5.55M 2.96M 11.05M 9.27M
Change to operating activities 0.78M 0.66M 0.12M -0.28M -0.80M
Net income -4.95M -10.41M -13.62M -25.02M -10.56M
Change in cash -1.56M 1.38M -1.66M 1.82M -0.06M
Begin period cash flow 1.99M 0.61M 2.27M 0.45M 0.51M
End period cash flow 0.43M 1.99M 0.61M 2.27M 0.45M
Total cash from operating activities -3.39M -4.15M -4.62M -9.06M -9.23M
Depreciation 0.06M 0.10M 0.19M 0.38M 0.35M
Dividends paid - - - - 0.00M
Change to inventory 0.08M -0.54M 0.33M -0.65M -0.17M
Change to account receivables -0.18M 0.18M 0.40M 0.51M -1.29M
Other cashflows from financing activities 2.05M 5.55M 2.96M 11.57M 9.32M
Change to netincome 0.48M 6.02M 8.41M 16.14M 2.46M
Capital expenditures 50185.00M 0.01M 0.01M 0.16M 0.10M
Change in working capital 1.01M 0.14M 0.40M -0.57M -1.49M
Stock based compensation 0.38M 0.38M 0.82M 1.78M 1.35M
Other non cash items 0.11M 5.63M 0.41M 0.18M 1.14M
Free cash flow 50181.61M -4.16M -4.62M -9.22M -9.33M

Peer Comparison*

Sector: Healthcare Industry: Medical Care Facilities

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
BNKL
Bionik Laboratories Corp
-
-%
0.00 - - 0.00 8.04 3.64 -1.10
HCA
HCA Healthcare, Inc.
15.19
3.30%
475.52 14.27 13.46 1.21 291.34 1.83 8.99
THC
Tenet Healthcare Corporation
-0.10
0.04%
263.49 10.08 12.66 0.96 4.57 1.43 5.80
FSNUY
Fresenius SE & Co KGaA ADR
-0.22
1.52%
14.00 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc
1.31
30.75%
5.57 62.50 35.97 0.30 2.32 0.16 3.90

Profile*

Bionik Laboratories Corp

Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.

80 Coolidge Hill Road, Watertown, MA, United States, 02472

617 926 4800

12

Name Title Year Born
Mr. Richard Paul Russo Jr., CPA CEO, Pres & Director 1980
Mr. Michal Prywata Co-Founder & Director 1991
Mr. Daniel Gonsalves CPA Exec. VP & CFO 1983
Mr. John Smathers Director of Operations NA
Mr. Mark Eiseman Sales Director NA
Mr. Richard Paul Russo Jr., CPA CEO, President & Director 1981
Mr. Daniel Gonsalves CPA Executive VP & CFO 1984

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…